RNA5SP116

Across TCGA pan-cancer cohorts, RNA5SP116 RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated RNA5SP116 data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher RNA5SP116 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNA5SP116 expression acts as an unfavorable survival marker.

BRCA, STAD, and LGG are the cancer types where RNA5SP116 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	DFS	Tertile	II,III,IV	0.470	0.891	<.001	60	view →
STAD	DFS	Tertile	All	0.460	0.671	.003	54	view →
LGG	OS	Tertile	All	0.204	0.799	<.001	18	view →
PCPG	DFS	Tertile	All	0.063	0.924	<.001	18	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

RNA5SP116–BRCA (DFS)

Open the BRCA breakdown →